Johnson Health Tech .Co., Ltd.

TWSE:1736 Stock Report

Market Cap: NT$44.2b

Johnson Health Tech .Co Future Growth

Future criteria checks 4/6

Johnson Health Tech .Co is forecast to grow earnings and revenue by 33.4% and 12.4% per annum respectively. EPS is expected to grow by 33.7% per annum. Return on equity is forecast to be 24.5% in 3 years.

Key information

33.4%

Earnings growth rate

33.7%

EPS growth rate

Leisure earnings growth24.2%
Revenue growth rate12.4%
Future return on equity24.5%
Analyst coverage

Low

Last updated25 Sep 2024

Recent future growth updates

Recent updates

Johnson Health Tech .Co's (TWSE:1736) Returns On Capital Are Heading Higher

Oct 16
Johnson Health Tech .Co's (TWSE:1736) Returns On Capital Are Heading Higher

Johnson Health Tech .Co., Ltd.'s (TWSE:1736) 28% Jump Shows Its Popularity With Investors

Sep 30
Johnson Health Tech .Co., Ltd.'s (TWSE:1736) 28% Jump Shows Its Popularity With Investors

News Flash: Analysts Just Made A Meaningful Upgrade To Their Johnson Health Tech .Co., Ltd. (TWSE:1736) Forecasts

Sep 26
News Flash: Analysts Just Made A Meaningful Upgrade To Their Johnson Health Tech .Co., Ltd. (TWSE:1736) Forecasts

Are Johnson Health Tech .Co., Ltd. (TWSE:1736) Investors Paying Above The Intrinsic Value?

Sep 23
Are Johnson Health Tech .Co., Ltd. (TWSE:1736) Investors Paying Above The Intrinsic Value?

Is Johnson Health Tech .Co (TWSE:1736) A Risky Investment?

Sep 05
Is Johnson Health Tech .Co (TWSE:1736) A Risky Investment?

Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Jul 16
Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Share Price Boosted 26% But Its Business Prospects Need A Lift Too

Investors Appear Satisfied With Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Prospects As Shares Rocket 32%

May 08
Investors Appear Satisfied With Johnson Health Tech .Co., Ltd.'s (TWSE:1736) Prospects As Shares Rocket 32%

Does Johnson Health Tech .Co (TWSE:1736) Have A Healthy Balance Sheet?

Apr 09
Does Johnson Health Tech .Co (TWSE:1736) Have A Healthy Balance Sheet?

The Strong Earnings Posted By Johnson Health Tech .Co (TWSE:1736) Are A Good Indication Of The Strength Of The Business

Mar 23
The Strong Earnings Posted By Johnson Health Tech .Co (TWSE:1736) Are A Good Indication Of The Strength Of The Business

Johnson Health Tech .Co (TWSE:1736) Shareholders Will Want The ROCE Trajectory To Continue

Mar 06
Johnson Health Tech .Co (TWSE:1736) Shareholders Will Want The ROCE Trajectory To Continue

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Extensively

Apr 26
These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Extensively

Investors Met With Slowing Returns on Capital At Johnson Health Tech (TPE:1736)

Mar 27
Investors Met With Slowing Returns on Capital At Johnson Health Tech (TPE:1736)

Did You Miss Johnson Health Tech's (TPE:1736) Impressive 180% Share Price Gain?

Feb 25
Did You Miss Johnson Health Tech's (TPE:1736) Impressive 180% Share Price Gain?

Should Johnson Health Tech. Co., Ltd. (TPE:1736) Focus On Improving This Fundamental Metric?

Feb 10
Should Johnson Health Tech. Co., Ltd. (TPE:1736) Focus On Improving This Fundamental Metric?

These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Reasonably Well

Jan 26
These 4 Measures Indicate That Johnson Health Tech (TPE:1736) Is Using Debt Reasonably Well

Do Institutions Own Johnson Health Tech. Co., Ltd. (TPE:1736) Shares?

Jan 11
Do Institutions Own Johnson Health Tech. Co., Ltd. (TPE:1736) Shares?

Returns On Capital At Johnson Health Tech (TPE:1736) Paint An Interesting Picture

Dec 27
Returns On Capital At Johnson Health Tech (TPE:1736) Paint An Interesting Picture

The Johnson Health Tech (TPE:1736) Share Price Has Gained 144%, So Why Not Pay It Some Attention?

Nov 27
The Johnson Health Tech (TPE:1736) Share Price Has Gained 144%, So Why Not Pay It Some Attention?

Earnings and Revenue Growth Forecasts

TWSE:1736 - Analysts future estimates and past financials data (TWD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202657,9943,2064,0434,9561
12/31/202553,2812,8562,2613,1661
12/31/202447,2722,0511,1562,0901
9/30/202443,1311,2831,2762,076N/A
6/30/202440,7321,1773,1643,932N/A
3/31/202439,0601,2194,1174,948N/A
12/31/202338,0707103,1353,843N/A
9/30/202336,8385901,9892,404N/A
6/30/202335,19144428465N/A
3/31/202333,122-300-632-291N/A
12/31/202233,613429-48392N/A
9/30/202231,863369-1,071-238N/A
6/30/202231,052-361-1,469-651N/A
3/31/202231,03653-3,659-2,818N/A
12/31/202130,77938-4,295-3,537N/A
9/30/202130,76553-3,341-2,681N/A
6/30/202131,0241,011-1,542-798N/A
3/31/202130,1029991,2792,005N/A
12/31/202028,3676792,1072,942N/A
9/30/202026,9018941,8182,563N/A
6/30/202025,5847841,6802,409N/A
3/31/202025,5701,015176990N/A
12/31/201925,3731,293234943N/A
9/30/201924,4601,12974695N/A
6/30/201923,708979-56591N/A
3/31/201922,6096127431,337N/A
12/31/201821,757390348981N/A
9/30/201820,769189131956N/A
6/30/201820,00967N/A954N/A
3/31/201819,540-6N/A13N/A
12/31/201719,494130N/A-74N/A
9/30/201719,477358N/A-939N/A
6/30/201719,958453N/A-215N/A
3/31/201720,191716N/A818N/A
12/31/201620,165716N/A1,258N/A
9/30/201619,659710N/A2,014N/A
6/30/201618,764769N/A282N/A
3/31/201617,963563N/A-154N/A
12/31/201516,975564N/A-217N/A
9/30/201516,5201,940N/A-813N/A
6/30/201516,3451,976N/A703N/A
3/31/201516,3132,296N/A2,482N/A
12/31/201416,5512,638N/A1,851N/A
9/30/201416,2621,477N/A2,232N/A
6/30/201415,9391,366N/A1,642N/A
3/31/201415,4161,058N/A398N/A
12/31/201315,071857N/A773N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 1736's forecast earnings growth (33.4% per year) is above the savings rate (1.1%).

Earnings vs Market: 1736's earnings (33.4% per year) are forecast to grow faster than the TW market (19.3% per year).

High Growth Earnings: 1736's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 1736's revenue (12.4% per year) is forecast to grow slower than the TW market (12.5% per year).

High Growth Revenue: 1736's revenue (12.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: 1736's Return on Equity is forecast to be high in 3 years time (24.5%)


Discover growth companies